Susan P. Stimson is CSO at Intersect ENT, Inc. (XENT). They have made 4 open-market trades across 1 company since 2019, most recently 2019-06-13.
CIK 0001614499
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XENT | 35,982 | $1.0M |
Shares reported on the most recent Form 4, priced at the 2019-06-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XENT | SELL · 10b5-1 | 2019-06-13 | 2019-06-17 | $25.00 | $9K | -7.3% | -17.5% | -26.0% |
| XENT | SELL | 2019-05-10 | 2019-05-14 | $27.38 | $146K | -2.4% | -3.5% | -38.2% |
| XENT | SELL | 2019-04-29 | 2019-05-01 | $31.06 | $388K | -15.2% | -27.0% | -37.7% |
| XENT | SELL | 2019-04-23 | 2019-04-24 | $30.00 | $80K | +12.7% | -14.4% | -31.9% |
| XENT | SELL | 2019-04-10 | 2019-04-12 | $29.13 | $291K | +4.2% | -4.8% | -28.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.